As of 2025-07-15, the Relative Valuation of G1 Therapeutics Inc (GTHX) is (18.54) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.15 USD, the upside of G1 Therapeutics Inc based on Relative Valuation is -359.3%.
The range of the Relative Valuation is (12.05) - (22.82) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.7x - 26.9x | 20.3x |
| Forward P/E multiples | 14.2x - 32.6x | 23.4x |
| Fair Price | (12.05) - (22.82) | (18.54) |
| Upside | -268.5% - -419.2% | -359.3% |
| Date | P/E |